Table 2.
Common themes | Description | Action steps | Kotter’s change theory |
---|---|---|---|
Provide leadership support | Leadership that can build organization-wide consensus for prioritize safe opioid prescribing. | Identify change agent (coalition team) to spearhead practice change initiatives. | Create a sense of urgency Build a core coalition |
Define standard of work | Revise and implement opioid therapy policies and define standard of work for providers and staff to achieve safer opioid prescribing. | Convene team from each clinic department to create and communicate the change initiative. Update patient agreement and revise to ensure alignment with clinic and guideline policies. |
Develop a vision and strategy Communicate the strategic vision Empower broad-based action |
Conduct pre-visit reviews | Conduct pre-visit planning and screening for comorbidities and prescription aberrancies. | Review outside medical records. Review state prescription monitoring program patient data. Implement new patient exclusion criteria. |
Generate short-term wins. |
Conduct post-visit reviews | Conduct post-visit chart reviews for opioid outliers. | Monitor and adjust opioid therapy based upon function not pain scale. Conduct team reviews of outliers for consensus of care. Discharge outliers to improve staff efficiencies. Identify referral sources for behavior and mental health (eg, opioid abuse disorder). |
Consolidate gains and produce more change. |
Measure progress | Continuously monitor progress and improve with experience. | Identify key processes and outcome measures to monitor change implementation. Monitor prescription practices, provide and discussing data with medical providers and support staff at regular meetings (no less then monthly). |
Anchor new approaches in the corporate culture. |